2012 EDUCATIONAL BOOK - American Society of Clinical Oncology

13. Allen LR, Lago-Toro CE, Hughes JH, et al. Is there a role for MRI in the
pre-operative assessment of patients with DCIS? Ann Surg Oncol. 2010;17:
2395-2400.
14. Katz A, Gage I, Evans S, et al. Sentinel lymph node positivity of
patients with ductal carcinoma in situ or microinvasive breast cancer. Am J
Surg. 2006;191:761-766.
15. Bruening W, Fontarosa J, Tipton K, et al. Systematic review: Comparative
effectiveness of core-needle and open surgical biopsy to diagnose breast
lesions. Ann Intern Med. Epub 2009 Dec 15.
16. Wong SL, Edwards MJ, Chao C, et al. The effect of prior breast biopsy
method and concurrent definitive breast procedure on success and accuracy of
sentinel lymph node biopsy. Ann Surg Oncol. 2002;9:272-277.
17. Schneider C, Trocha S, McKinley B, et al. The use of sentinel lymph
node biopsy in ductal carcinoma in situ. Am Surg. 2010;76:943-946.
18. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the
National Surgical Adjuvant Breast Project (NSABP) eight-year update of
Protocol B-17: intraductal carcinoma. Cancer. 1999;86:429-438.
19. Joslyn SA. Ductal carcinoma in situ: Trends in geographic, temporal,
and demographic patterns of care and survival. Breast J. 2006;12:20-27.
20. Li CI, Malone KE, Saltzman BS, Daling JR. Risk of invasive breast
carcinoma among women diagnosed with ductal carcinoma in situ and lobular
carcinoma in situ, 1988-2001. Cancer. 2006;106:2104-2112.
21. Dick AW, Sorbero MS, Ahrendt GM, et al. Comparative effectiveness of
ductal carcinoma in situ management and the roles of margins and surgeons.
J Natl Cancer Inst. 2011;103:92-104.
22. Holmes P, Lloyd J, Chervoneva I, et al. Prognostic markers and
long-term outcomes in ductal carcinoma in situ of the breast treated with
excision alone. Cancer. 2011;117:3650-3657.
23. Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment
with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of
48
VIRNIG, WANG, AND TUTTLE
European Organisation for Research and Treatment of Cancer randomized
phase III trial 10853—a study by the EORTC Breast Cancer Cooperative
Group and EORTC Radiotherapy Group. J Clin Oncol. 2006;24:3381-3387.
24. Holmberg L, Garmo H, Granstrand B, et al. Absolute risk reductions for
local recurrence after postoperative radiotherapy after sector resection for
ductal carcinoma in situ of the breast. J Clin Oncol. 2008;26:1247-1252.
25. Wapnir IL, Dignam JJ, Fisher B, et al. Long-term outcomes of invasive
ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24
randomized clinical trials for DCIS. J Natl Cancer Inst. 2011;103:478-488.
26. Meijnen P, Oldenburg HS, Peterse JL, et al. Clinical outcome after
selective treatment of patients diagnosed with ductal carcinoma in situ of the
breast. Ann Surg Oncol. 2008;15:235-243.
27. Schouten van der Velden AP, van Vugt R, Van Dijck JA,et al. Local
recurrences after different treatment strategies for ductal carcinoma in situ of
the breast: A population-based study in the East Netherlands. Int J Radiat
Oncol Biol Phys. 2007;69:703-710.
28. Jeruss JS, Kuerer HM, Beitsch PD, et al. Update on DCIS outcomes
from the American Society of Breast Surgeons accelerated partial breast
irradiation registry trial. Ann Surg Oncol. 2011;18:65-71.
29. Israel PZ, Vicini F, Robbins AB, et al. Ductal carcinoma in situ of the
breast treated with accelerated partial breast irradiation using balloon-based
brachytherapy. Ann Surg Oncol. 2010;17:2940-2944.
30. Keisch M, Vicini F, Beitsch P, et al. American Society of Breast
Surgeons MammoSite Radiation Therapy System Registry Trial: Ductal
carcinoma-in-situ subset analysis-4-year data in 194 treated lesions. Am J
Surg. 2009;198:505-507.
31. Fisher B, Land S, Mamounas E, et al. Prevention of invasive breast
cancer in women with ductal carcinoma in situ: An update of the national
surgical adjuvant breast and bowel project experience. Semin Oncol. 2001;28:
400-418.